← Leaderboards
Spyros A Kalams
Vanderbilt University Medical Center
$30,057,725
Attributed
$48,244,828
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$48,889,559 · 15
By mechanism
UM1$27,280,655 · 1
R01$6,065,849 · 2
P30$5,315,940 · 7
T32$3,795,981 · 1
P01$3,027,448 · 1
U19$2,533,169 · 1
Top collaborators
- David W Haas14 shared
- Rachel Margaret Presti10 shared
- David B Clifford4 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Scott Alan Smith$10,215,145
- David W Haas$38,631,058
- Rachel Margaret Presti$9,971,897
- Krystle A. Kuhs$3,664,442
- Samuel Stuart Bailin$557,808
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseAcquired Immunodeficiency SyndromePerformanceAreaDesignInfectionImmunologyVaccinesCellsT-LymphocyteProgramsHiv InfectionsImmune ResponseMissionCollaborationsFundingTechnologyResearch DesignHuman GenomicsResearch PersonnelMemberUniversitiesB-LymphocytesSorting - Cell Movement
Grant awards (82)
Vanderbilt HIV Clinical Trials Unit (CTU)$2,720,209
UM1 · FY2025 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$412,245
T32 · FY2025 · AI · contact PI
Advanced Technologies Core (Core D)$231,924
P30 · FY2025 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit (CTU)$2,649,501
UM1 · FY2024 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$327,653
T32 · FY2024 · AI · contact PI
Laboratory Sciences Core (Core D)$284,284
P30 · FY2024 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit (CTU)$2,106,727
UM1 · FY2023 · AI
Single cell molecular analysis of influenza vaccine responses in elderly individuals$474,941
R01 · FY2023 · AI · contact PI
Single cell molecular analysis of influenza vaccine responses in elderly individuals$436,516
R01 · FY2023 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$259,100
T32 · FY2023 · AI · contact PI
Laboratory Sciences Core (Core D)$234,627
P30 · FY2023 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit (CTU)$2,679,601
UM1 · FY2022 · AI
Single cell molecular analysis of influenza vaccine responses in elderly individuals$473,934
R01 · FY2022 · AI · contact PI
Laboratory Sciences Core (Core D)$332,948
P30 · FY2022 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$311,579
T32 · FY2022 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit (CTU)$2,577,612
UM1 · FY2021 · AI
Laboratory Sciences Core (Core D)$509,946
P30 · FY2021 · AI · contact PI
Single cell molecular analysis of influenza vaccine responses in elderly individuals$494,406
R01 · FY2021 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$363,222
T32 · FY2021 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$2,487,433
UM1 · FY2020 · AI
Vanderbilt CTU SARS-CoV-2 Supplement$558,406
UM1 · FY2020 · AI
Single cell molecular analysis of influenza vaccine responses in elderly individuals$508,278
R01 · FY2020 · AI · contact PI
Laboratory Sciences Core (Core D)$293,700
P30 · FY2020 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$2,941,559
UM1 · FY2019 · AI
Single cell molecular analysis of influenza vaccine responses in elderly individuals$509,913
R01 · FY2019 · AI · contact PI
Laboratory Sciences Core$372,175
P30 · FY2019 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$301,159
T32 · FY2019 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$1,615,311
UM1 · FY2018 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$275,212
T32 · FY2018 · AI · contact PI
Laboratory Sciences Core$238,254
P30 · FY2018 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$1,003,759
UM1 · FY2017 · AI
Laboratory Sciences Core$361,313
P30 · FY2017 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$256,135
T32 · FY2017 · AI · contact PI
Molecular analysis of the adaptive immune response to tuberculosis$197,500
R21 · FY2017 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$1,224,853
UM1 · FY2016 · AI
Vanderbilt HIV Clinical Trials Unit$395,433
UM1 · FY2016 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$297,050
T32 · FY2016 · AI · contact PI
Laboratory Sciences Core$242,528
P30 · FY2016 · AI · contact PI
Molecular analysis of the adaptive immune response to tuberculosis$234,100
R21 · FY2016 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$1,603,813
UM1 · FY2015 · AI
Laboratory Sciences Core$227,997
P30 · FY2015 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$162,081
T32 · FY2015 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$130,428
T32 · FY2015 · AI · contact PI
Vanderbilt HIV Clinical Trials Unit$2,716,438
UM1 · FY2014 · AI
Characterization of T & B cell responses correlated with broad neutralizing Abs$369,503
P01 · FY2014 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$241,426
T32 · FY2014 · AI · contact PI
Characterization of T & B cell responses correlated with broad neutralizing Abs$568,070
P01 · FY2013 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$246,254
T32 · FY2013 · AI · contact PI
Characterization of T & B cell responses correlated with broad neutralizing Abs$505,489
P01 · FY2012 · AI · contact PI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$212,437
T32 · FY2012 · AI · contact PI
Vanderbilt Meharry Center for AIDS Research$644,731
P30 · FY2011 · AI · contact PI
Characterization of T & B cell responses correlated with broad neutralizing Abs$522,409
P01 · FY2011 · AI · contact PI
HIV IMMUNOPATHOGENESIS$142,287
P30 · FY2011 · AI · contact PI
Characterization of T & B cell responses correlated with broad neutralizing Abs$530,363
P01 · FY2010 · AI · contact PI
HIV IMMUNOPATHOGENESIS$226,621
P30 · FY2010 · AI · contact PI
Pro-Apoptotic BCG as an HCV vaccine vector$193,292
R21 · FY2010 · AI · contact PI
Characterization of T & B cell responses correlated with broad neutralizing Abs$531,614
P01 · FY2009 · AI · contact PI
HIV IMMUNOPATHOGENESIS$299,022
P30 · FY2009 · AI · contact PI
Molecular Analysis of HCV-specific T Cell Responses$255,343
U19 · FY2009 · AI · contact PI
Pro-Apoptotic BCG as an HCV vaccine vector$245,625
R21 · FY2009 · AI · contact PI
HIV IMMUNOPATHOGENESIS$259,197
P30 · FY2008 · AI · contact PI
Molecular Analysis of HCV-specific T Cell Responses$247,325
U19 · FY2008 · AI · contact PI
Molecular Analysis of HCV-specific T Cell Responses$250,240
U19 · FY2007 · AI · contact PI
HIV IMMUNOPATHOGENESIS$232,748
P30 · FY2007 · AI · contact PI
TCR Genes and HIV-Specific Cytotoxic T-lymphocytes$541,387
R01 · FY2006 · AI · contact PI
Molecular Analysis of HCV-specific T Cell Responses$238,362
U19 · FY2006 · AI · contact PI
HIV IMMUNOPATHOGENESIS$181,638
P30 · FY2006 · AI · contact PI
TCR Genes and HIV-Specific Cytotoxic T-lymphocytes$538,266
R01 · FY2005 · AI
Molecular Analysis of HCV-specific T Cell Responses$239,293
U19 · FY2005 · AI
TCR Genes and HIV-Specific Cytotoxic T-lymphocytes$526,481
R01 · FY2004 · AI
TCR Genes and HIV-Specific Cytotoxic T-lymphocytes$536,642
R01 · FY2003 · AI
Molecular analysis of HCV T cell responses$434,202
U19 · FY2002 · AI
TCR Genes and HIV-Specific Cytotoxic T-lymphocytes$337,853
R01 · FY2002 · AI
TCR Genes and HIV-Specific Cytotoxic T-lymphocytes$255,790
R01 · FY2002 · AI
Core--Immunology$0
P30 · FY2002 · AI
Core--Immunology$0
P30 · FY2002 · AI
Molecular analysis of HCV T cell responses$434,202
U19 · FY2001 · AI
TCR GENE USAGE AND QUANTITATION OF HIV SPECIFIC CTL$218,911
R01 · FY2001 · AI
Core--Immunology$0
P30 · FY2001 · AI
Molecular analysis of HCV T cell responses$434,202
U19 · FY2000 · AI
TCR GENE USAGE AND QUANTITATION OF HIV SPECIFIC CTL$212,531
R01 · FY2000 · AI
Core--Immunology$0
P30 · FY2000 · AI